病例报告:冠状动脉样硬化症患者长期患有非常低的LDL-C,没有降脂治疗
Giorgio Mottola1, Francine K Welty2, Hamid R Mojibian3
1Department of Medicine, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, United States.
Frontiers in cardiovascular medicine
|October 5, 2023
概括
即使低密度脂蛋白胆固醇 (LDL-C) 的水平非常低,也可能无法完全预防动脉样硬化. 这一案例凸显了管理所有心血管风险因素对于原始预防的重要性.
科学领域:
- 心脏病学 心脏病学
- 脂质代谢 脂质代谢是什么
- 动脉样硬化研究 动脉样硬化研究
背景情况:
- 含有Apolipoprotein B (ApoB) 的脂蛋白,包括低密度脂蛋白胆固醇 (LDL-C),是动脉样硬化发展的组成部分.
- 终身暴露于低LDL-C水平与心血管风险降低有关.
- 虽然在治疗时LDL-C<70-80 mg/dl时发生斑块回归,但预防动脉样硬化的确定的LDL-C值仍然未知.
研究的目的:
- 介绍一个案例研究,说明极低的LDL-C水平与动脉样硬化之间的关系.
- 强调全面的心血管风险因素管理的必要性.
主要方法:
- 一个60岁的男性患有糖尿病和高血压,出现中风后的病例报告.
- 冠状动脉计算机断层扫描血管学 (CCTA) 进行手术前评估.
- 对16年来患者的LDL-C水平实验室数据的审查.
主要成果:
- 这位患者出现了心房肌瘤和非阻塞性冠状动脉样硬化症.
- 冠状动脉计算机断层扫描血管学揭示了异常的右冠状动脉起源和动脉样硬化.
- 在没有降脂治疗的情况下,该患者始终表现出低LDL-C水平 (<40 mg/dl).
- 家庭病史表明异构卵性家族性低贝塔利蛋白血症.
结论:
- 极低,长期存在的LDL-C水平可能无法完全预防动脉样硬化.
- 对所有心血管风险因素的全面管理对于预防动脉样硬化至关重要.
- 这一案例强调了原始预防策略的重要性.
更多相关视频
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
3.9K
07:35Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
Published on: December 10, 2021
2.0K
相关概念视频
01:26Coronary Artery Disease IV: Preventive Measures
23
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
01:30Coronary Artery Disease I: Introduction
19
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
19
01:26Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
01:26Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
11
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
11
01:27Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9